THE EFFECT OF NOVEL COMPOUND MCC950 ON THE NLRP3 INFLAMMASOME IN THE RA JOINT

被引：2
|
作者：
McGarry, T. [1 ]
Robertson, A. A. [2 ]
Orr, C. [1 ]
Coll, R. C. [3 ]
Cooper, M. A. [2 ]
O'Neill, L. A. [3 ]
Veale, D. J. [1 ]
Fearon, U. [1 ]
机构：
[1] Univ Coll Dublin, Dublin Acad Med Ctr, Ctr Arthrit & Rheumat Dis, Dublin, Ireland
[2] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia
[3] Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin, Ireland
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.3985
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0027
引用
收藏
页码：202 / 202
页数：1
相关论文
共 50 条
  • [1] Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome
    Li, Hao
    Guan, Yanling
    Liang, Bo
    Ding, Peng
    Hou, Xin
    Wei, Wei
    Ma, Yang
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, 928
  • [2] Integrated Proteomics Characterization of NLRP3 Inflammasome Inhibitor MCC950 in Monocytic Cell Line Confirms Direct MCC950 Engagement with Endogenous NLRP3
    Zhao, Heng
    Kumar, Praveen
    Sobreira, Tiago Jose Paschoal
    Smith, Mackenzie
    Novick, Steven
    Johansson, Anders
    Luchniak, Anna
    Zhang, Andrew
    Woollard, Kevin J.
    Larsson, Niklas
    Kawatkar, Aarti
    ACS CHEMICAL BIOLOGY, 2024, 19 (04) : 962 - 972
  • [3] MCC950 is a potent and specific inhibitor of the NLRP3 inflammasome and a novel potential therapeutic for NLRP3 driven diseases
    Coll, Rebecca C.
    Robertson, Avril A. B.
    Chae, Jae Jin
    Higgins, Sarah C.
    Dungan, Lara S.
    Munoz-Planillo, Raul
    Monks, Brian G.
    Croker, Daniel E.
    Sutton, Caroline E.
    Stutz, Andrea
    Nunez, Gabriel
    Latz, Eicke
    Kastner, Daniel L.
    Mills, Kingston H. G.
    Masters, Seth L.
    Schroder, Kate
    Cooper, Matt A.
    O'Neill, Luke A. J.
    CYTOKINE, 2014, 70 (01) : 35 - 35
  • [4] Target of MCC950 in Inhibition of NLRP3 Inflammasome Activation: a Literature Review
    Wu, Danbin
    Chen, Yefei
    Sun, Yingxin
    Gao, Qing
    Li, Huhu
    Yang, Zhengfei
    Wang, Yangxue
    Jiang, Xijuan
    Yu, Bin
    INFLAMMATION, 2020, 43 (01) : 17 - 23
  • [5] Target of MCC950 in Inhibition of NLRP3 Inflammasome Activation: a Literature Review
    Danbin Wu
    Yefei Chen
    Yingxin Sun
    Qing Gao
    Huhu Li
    Zhengfei Yang
    Yangxue Wang
    Xijuan Jiang
    Bin Yu
    Inflammation, 2020, 43 : 17 - 23
  • [6] Blockage of the NLRP3 inflammasome by MCC950 inhibits migration and invasion in adenomyosis
    Liu, Yanping
    Jiang, Zhou
    Zhang, Lu
    Tian, Wei
    Lin, Aimin
    Li, Mingjiang
    REPRODUCTIVE BIOMEDICINE ONLINE, 2024, 49 (04)
  • [7] Inhibition of the NLRP3 Inflammasome by MCC950 Accelerates Renal Injury in Diabetes Model
    Ostergaard, Jakob A.
    Jha, Jay C.
    Sharma, Arpeeta
    Dai, Aozhi
    Cooper, Mark E.
    de Haan, Judy B.
    Jandeleit-Dahm, Karin
    DIABETES, 2020, 69
  • [8] A Probe for NLRP3 Inflammasome Inhibitor MCC950 Identifies Carbonic Anhydrase 2 as a Novel Target
    Kennedy, Cassandra R.
    Grocin, Andrea Goya
    Kovacic, Tristan
    Singh, Ravi
    Ward, Jennifer A.
    Shenoy, Avinash R.
    Tate, Edward W.
    ACS CHEMICAL BIOLOGY, 2021, 16 (06) : 982 - 990
  • [9] Synthesis of deuterium-labelled analogues of NLRP3 inflammasome inhibitor MCC950
    Salla, Manohar
    Butler, Mark S.
    Massey, Nicholas L.
    Reid, Janet C.
    Cooper, Matthew A.
    Robertson, Avril A. B.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (04) : 793 - 795
  • [10] Inhibiting the NLRP3 Inflammasome with MCC950 Alleviates Neurological Impairment in the Brain of EAE Mice
    Hou, Baohua
    Yin, Jun
    Liu, Shuyan
    Guo, Jincheng
    Zhang, Baobao
    Zhang, Zhenzhen
    Yang, Lanping
    Tan, Xiying
    Long, Yijiao
    Feng, Sijie
    Zhou, Jingchun
    Wu, Yifan
    Wang, Xueyang
    Han, Song
    Wang, Zhenhui
    He, Xiaohua
    MOLECULAR NEUROBIOLOGY, 2024, 61 (03) : 1318 - 1330
12345